MeVis Medical Solutions AGFRA:M3V 66 Median PS Value is €29.30 as of Jun. 28, 2026, which is 100% below its 10-year median of 1.14. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 262 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks worse than 59.54% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for MeVis Medical Solutions AG's Median PS Value or its related term are showing as below:
FRA:M3V'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.73 Med: 1.14 Max: 1.89
Current: 0.79
During the past 13 years, the highest Price to Median PS Value of MeVis Medical Solutions AG was 1.89. The lowest was 0.73. And the median was 1.14.
FRA:M3V's Price-to-Median-PS-Value is ranked worse than 59.54% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.69
vs FRA:M3V: 0.79
MeVis Medical Solutions AG (FRA:M3V) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
MeVis Medical Solutions AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
23.20
/
29.30
=
0.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG Median PS Value Related Terms
MeVis Medical Solutions AG Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Median PS Value Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.4442.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MeVis Medical Solutions AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €8.507.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a Median PS Value of €29.30 as of Jun. 28, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on MeVis Medical Solutions AG and its competitors. This is 2470% above median its historical median of 1.14. Over the past decade, MeVis Medical Solutions AG's Median PS Value has ranged from 0.73 to 1.89. According to the industry distribution chart, MeVis Medical Solutions AG ranks #156 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 59.5%.
Is MeVis Medical Solutions AG's Median PS Value too high?
MeVis Medical Solutions AG's current Median PS Value of €29.30 is 2470% above median its 10-year median of 1.14. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 1.89. Based on the distribution chart, MeVis Medical Solutions AG ranks #156 out of 262 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Median PS Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #156 out of 262 companies for Median PS Value. This places MeVis Medical Solutions AG in the lower half of its industry. The industry median Median PS Value is 0.69. Historically, MeVis Medical Solutions AG's own Median PS Value has ranged from 0.73 to 1.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.69, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Median PS Value is €29.30, which is 2470% above median its own 10-year median of 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Median PS Value of €29.30. The stock's GF Value™ is €22.52, compared to a current price of €23.20 — trading 3% above its estimated fair value. The current Median PS Value is €29.30, which is 2470% above median its 10-year median of 1.14. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Median PS Value is €29.30 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.20 is trading 3% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Median PS Value: €29.30 (2470% above median its 10-year median of 1.14)
GF Value™: €22.52 vs. price of €23.20 (3% above fair value)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
